From 2022 to 2027, the global cell banking outsourcing market is expected to develop at a CAGR of 15.24 percent, from USD 9,204.22 million in 2022 to USD 18,706.96 million in 2027.
Browse details of the report @ https://www.marketdataforecast.com/market-reports/cell-banking-outsourcing-market
Some sectors stopped producing and supplying products during the early phases of the epidemic. The coronavirus outbreak, which impeded the cell banking outsourcing sector at first, has caused huge losses for the majority of pharmaceutical companies. Several businesses shut down manufacturing and supply operations during the early phases of the epidemic. The current COVID-19 scenario is expected to return to normal as medical professionals and health officials in impacted countries take the required actions to tackle the virus. However, when medical specialists and health authorities around the world take the required steps to combat the virus, the current COVID-19 situation is likely to stabilise. Due to the extensive use of cell-based treatments for COVID-19 therapy, cell banking services such as processing and storage are expected to be in high demand. As a result, market growth is expected to be boosted by the increased prevalence of COVID-19 over the forecast period.
Several businesses stopped manufacturing and supplying during the early phases of the outbreak. The current COVID-19 scenario is expected to return to normal as medical professionals and health authorities in the countries make the necessary steps to combat the virus. According to the European Society for Blood and Marrow Transplantation, infected donors should wait at least 21 days before donating blood. Donors of tissue and stem cells in Italy have been advised by the National Transplant Centre. Several studies are being conducted throughout the world to see if Mesenchymal Stem Cells (MSCs) can help alleviate some of the effects COVID-19 has on the respiratory system.
The impact of COVID-19 on cord blood banking around the world was examined in a Blood Research article published online on March 12, 2021. In South Korea in 2019 and 2020, the number of unrelated Stem Cell Transplantations (SCTs) using bone marrow or peripheral blood was similar. As a result, the COVID-19 epidemic in Korea had no substantial impact on SCT donations. However, after March 2020, the number of volunteer adult stem cell donors fell sharply for several months, compared to 2018 and 2019, before rebounding after July 2020. Similarly, several medications have been tested in clinical trials, and stem cells and cord blood were employed in 10.2 percent of COVID-19 studies to try to prevent the disease from progressing. The demand for cell banking services such as storage and processing is expected to rise as the dependence on cell-based therapies for possible COVID-19 treatment grows.
The global cell banking outsourcing market is predicted to be driven by increased demand for biopharmaceutical manufacturing targeting novel active sites, stem cell therapy, and gene therapy.
The growing number of clinical trials has served to reveal the potential of stem cells and their uses, which has fuelled the growth of the global cell banking outsourcing market. Similarly, throughout the forecast period, expanding government measures to support stem cell isolation and its associated benefits, as well as improved awareness of stem cell banking in a number of emerging nations, are likely to affect market expansion. Furthermore, increased stem cell research efforts are expected to propel market growth throughout the forecast period.
Cell preservation is accomplished by first proliferating cells, which then proliferate into numerous identical cells, which are then stored in cryovials for future use. During the projected period, increased average life expectancy as a result of enhanced medical research and improved population lifestyles, as well as simple legislation for stem cell researchers, are expected to offer substantial market potential. Simultaneously, the rising popularity of adipose tissue banking has created a great opportunity. Leading firms are repositioning themselves and expanding their regional reach in response to the growing worldwide demand for cell and gene-based therapies for various objectives. Significant competitors’ recent mergers and acquisitions also have an impact on the worldwide cell banking outsourcing market. Rising stem cell utilisation and clinical trials are also likely to fuel the worldwide cell banking outsourcing market.
The worldwide cell banking outsourcing market is primarily influenced by the growing number of stem cell therapies around the world. Between 2006 and 2014, almost 1 million hematopoietic stem cell transplantation procedures were performed, according to a survey undertaken by the World Network for Blood and Marrow Transplantation (WBMN). These diagrams depicted the procedures for extracting stem cells from peripheral blood or bone marrow, multiplying them, and then storing them in cell banks for future use by patients. Multiple diseases, such as amyotrophic lateral sclerosis, type 1 diabetes, cancer, Alzheimer’s disease, Parkinson’s disease, and others, can be treated with stem cell therapy. The ability to heal such a wide range of ailments is projected to drive the global cell banking outsourcing market forward in the coming years.
Characterization of cell lines is aided by cell banks. By storing and retrieving cell lines as needed, they lower the cost of cell culture methods. Similarly, the growing emphasis on regenerative and customised medicine is expected to fuel growth in the cell banking outsourcing industry. Due to well-established healthcare infrastructure, large patient populations, and significant healthcare expenditures, several key businesses focus on tailoring products and services to the American and European markets. There are no public cord blood banks in Africa, and importing cord blood units from other countries is prohibitively expensive for most patients. With first-to-market advantage, launching subsidiaries in developing regions can be advantageous.
Concerns concerning donor disclosure in light of vital clinical information revealed during the donor screening phase, as well as concerns with the methodologies used to acquire informed permission from potential cord blood donors, are limiting the cell banking outsourcing market’s expansion. Furthermore, the expensive cost of keeping these cells in cell banks is a major barrier to the worldwide cell banking outsourcing market.
Avail sample market brochure of the report to evaluate report usefulness, get a copy @ https://www.marketdataforecast.com/market-reports/cell-banking-outsourcing-market/request-sample
KEY MARKET INSIGHTS:
- Based on bank type, master cell banking held the largest share of the worldwide cell banking outsourcing market in 2020. Master cell banks also contribute in the creation of functional cell banks and have been employed in a number of stem cell and gene therapy research and development initiatives, leading in segment expansion.
- Because to favourable government guidelines, the presence of big enterprises, and increased healthcare expenditure in the region, the North American region’s cell bank outsourcing market held the largest share. The availability of a rising number of stem cell banks, both public and private, is expected to support the growth of the cell bank outsourcing industry globally. The CellPort Cell Culture Suite, a revolutionary cloud-based Software as a Service (SaaS) application focusing on cell culture and cell banking, was recently launched by CellPort Software. CellPort Cell Culture Suite is a secure, compliant SaaS application suite that manages all lab activities, workflows, materials, staff, locations, data/calculations, and cell banking and cell culture projects. CellPort reduces errors, boosts productivity, boosts reproducibility, and provides full audit-ready traceability in both regulated and uncontrolled environments.
- During the forecast period, the market for cell banking outsourcing is expected to grow at the fastest rate. The rising population, the growing number of patients suffering from chronic diseases such as oncological diseases, and the growing number of contract research and development organisations are all factors contributing to regional market growth. Clinical trials continue to expand fast across the region. Clinical biotech activity increased by 26% in 2019, according to Novotech (Australia), a contract research business. Furthermore, AstraZeneca, a British-Swedish pharmaceutical company, announced a long-term partnership with Samsung Biologics, a South Korean Contract Development and Manufacturing Organization (CDMO). Samsung Biologics has also announced a slew of deals with smaller biopharma companies, including UCB in Belgium, Cytodyn in the United States, PharmAbcine in South Korea, Panolos Bioscience in South Korea, Immunomedics in the United States, ImmuneOncia Therapeutics Inc. in South Korea, and STCube in South Korea. Furthermore, the high prevalence of chronic diseases such as cancer in the region is fuelling market growth. According to the Globocan 2020 report, the United States will see 2,281,658 new cancer cases diagnosed in 2020, with almost 612,390 deaths. Breast (253,465), lung (227,875), prostate (209,512), and colon (101,809) were the most common malignancies in the United States in 2020.
- Only a few of the leading firms in the global cell banking outsourcing market are Lifecell, Cryo-Cell, Toxikon, CordLife, Esperite, Reliance Life Sciences, Goodwin Biotechnology, Texcell, and Cryo Stemcell.
The report can be customized as per the requirements; talk to our team @ https://www.marketdataforecast.com/market-reports/cell-banking-outsourcing-market/customization
SEGMENTS INCLUDED IN THIS REPORT:
By Bank Type:
- Master Cell Banking
- Working Cell Banking
- Viral Cell Banking
By Cell Type:
- Stem Cell Banking
- Cord Stem Cell Banking
- Embryonic Stem Cell Banking
- Adult Stem Cell Banking
- Dental Stem Cell Banking
- IPS Stem Cell Banking
- Non-stem Cell Banking
By Phase:
- Cell Bank Storage
- Bank Characterization and Testing
- Cell Bank Preparation
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
About MarketDataForecast:
Market Data Forecast is a firm working in market research, business intelligence, and consulting. We have rich research and consulting experience for various business domains to cater to individual and corporate clients’ needs.
Contact Us:
Market Data Forecast
Phone: +1-888-702-9626
Email: contact@marketdataforecast.com